News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
San Diego, CA, November 1, 2018 – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID Panel designed to reduce the time and cost of performing chimerism analysis for bone marrow engraftment monitoring studies. The SNP-based panel is designed for research use with the MassARRAY® system and is... Read more
31 OCT 2018 Tags: Genomics, Agriculture Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies, a global leader in the design, development, and manufacture of sophisticated, custom oligonucleotide-based tools and associated reagents for applied markets, announced today that they have signed an... Read more
October 31, 2018 11:45 AM Pacific Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before... Read more
-Dovetail increases global footprint with seven new distributors – SANTA CRUZ, Calif., Oct. 31, 2018 /PRNewswire/ — Dovetail Genomics™ LLC, which offers genomic products and services to address unmet needs in both human and non-human markets, expanded its growing international distribution network by signing additional partnerships in India, Australia, New Zealand, Taiwan, China, Thailand and Vietnam. Dovetails tools are used to generate accurate chromosome scale genome... Read more
–Universal SOPHiA AI Platform Now Includes Paragon Genomics’ Accurate and Sensitive CleanPlex® NGS Target Enrichment Technology for Its Rapidly-Growing Global Community of Cancer Centers– –Separately, Paragon Genomics Announces CleanPlex® UMI Research Award Program Granting Winners Free CleanPlex UMI Custom Panels that Enable Allele Frequency Detection Down to 0.1% for Liquid Biopsy and Other Applications– –Visit AMP 2018... Read more
Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif., October 31, 2018 Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSightTM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers. TruSight Oncology 500 utilizes both DNA and RNA from subject tumor samples to identify key somatic variants underlying tumor progression, such as small DNA variants, fusions, and... Read more
October 30, 2018 08:00 ET | Source: Cofactor Genomics –Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions– SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) — Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the launch of a RNA-based immune profiling kit developed for laboratories wishing to derive... Read more
Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement SANTA CLARA, Calif., October 29, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed... Read more
Hilden, Germany, and Germantown, Maryland, October 29, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of major enhancements to QIAGEN Clinical Insight (QCI) bioinformatics solutions to deliver expanded Sample to Insight workflows for clinical next-generation sequencing (NGS). QIAGEN introduced QCI Analyze Universal for full end-to-end workflow support of all... Read more